I agree, once politics comes to a message board the whole thing spirals into chaos and the intelligent posters leave. Case in point the cldx board. If you haven't seen that one you should take a peak, they don't discuss the company at all, it's all hateful, heated, garbage. This board is the most informative I have ever been on, it would be a real shame to lose that.
If you guys want to talk politics perhaps you should be on the cldx board, what a complete joke that one is; The political nonsense drove anyone with any intelligence off that board and reduced it to "I know you are but what am I" postings. How about we start over fresh on Tuesday with what we all have in common, Exel.
Ino stock dropped in concert with the market after the poor GDP reading. Considering the Dow had the worst day in two months, and the Nasdaq and IBB got hammered, Ino did quite well to finish GREEN!
Sentiment: Strong Buy
Exel trades like a staircase, sometimes it heads for the basement, sometimes up. If you take a slightly longer view I believe you will be well rewarded. I am more optimistic now then I have ever been. I believe that we have a very successful company in the making, until it is bought out. Exel is my largest single investment, my second largest is MDVN which is in the middle of a potential buyout, this is my fourth biotech buyout in the last few years and is not what I invest for. However, of them all I still believe once the company becomes profitable (a diamond in the rough in the cancer field) Exel is very likely to be acquired. Just my opinion of course, but I put my money on it.
As a side note, there are more knowledgeable people on this board than any message board I have been on, the overwhelming sentiment seems optimistic (with good explanation as to why) and often it seems the news comes out later that confirms what was already discussed here, I look forward to Asco.
Sentiment: Strong Buy
"Nucynta is getting rejected by Dr.s"
Nucynta is not being rejected by doctors, I was recently prescribed it over percocet for my herniated discs pain and I know two other guys who just got on it, seems it's gaining traction if anything. I think a strong sell may be better suited when Depo is in the $30 range, unless sales continue higher, as they have been.
No one gives a rats #$%$ what you think, don't bother to review.
Stelios Papadopoulos "The Godfather of Biotech" is featured in an interview on Yahoo, "Where I see Valeant in Two Years. A little Advertising for Exel when on the screen was posted " Street Creds Exelixis Chairman and founder"
Just a little plug, Exel and the Godfather of Biotech...lol
"So is the problem price or is it a problem with the company ?
I don't think there is a problem at all, but as translationhell alluded too, it is too early. Once we have European approval and some sales figures then potential buyers will have data they can use to assess Exel. I'm looking to the positive, I think sales may be better than expected and pipeline goes from pipe-dream to reality. I have potential suitors in mind, Asco may shed more light on Exel's potential. Talk in biotech circles is to expect a lot of M&A in the sector, why not Exel.
Sentiment: Strong Buy
Unfortunately the news of Eisai's new drug approval stopped Exels rally in it's tracks and cost us a potentially great day yesterday when biotech was in full rally mode. I know It will come back, but for those who are fully loaded on the stock it was bad timing, I was hoping to see $6.00 this week and build on it going into Asco but as you imply, it could have been worse.
While Sanofi's offer is unacceptable Medivation needs to be open to a sale from someone. I know they want to go it alone (hey, if I was paying myself Millions of dollars a year I would) but for the sake of the stock holders I think the company needs to be sold. Anyone who has been around MDVN in the last couple of years knows how unresponsive the company is to shareholders, try and get any answer from the company on any question and you will wait forever. If MDVN goes it alone they will once again face the wrath of congress and perhaps even the next administration, which ever one it is and the pps will plummet. If it takes a board change to negotiate a sale in good faith then so be it.
For those who did not read this:
"No matter which party wins, reports suggest it’s unlikely for Medivation to go for any bid valued at less than $65 a share. Stifel analyst Thomas Shrader said in a March 2 research note that the company can go for as high as $85 a share if the acquirer accepts the perceived value of talazoparib to be equal to that of Xtandi. Meanwhile, Goldman Sachs analysts have suggested a takeaway price of $70 per share for the company, while Barclays expects an offer $15-20 above Sanofi’s $52.50 bid."
My bet stands unchanged at $75. Good Luck!
I'm just quoting the article here, two things stand out:
"Medivation is expecting a price higher than what Pharmacyclics received."
"It will probably get more than what Pharmacyclics received"
Any way you slice it, it sounds positive to me.
What are the chances that Ipsen press the EMA for first line in Europe, I'm certainly no expert regarding what each country uses as acceptable but perhaps the Ipsen news release was a strategic push?
The more the merrier. If Sanofi want to take on a hostile buyout and go straight to the shareholders what do you think the shareholders are going to say to a sub $60.00 offer! If that's all they wanted they would have all sold already.
He is obviously losing all of his unemployment money betting against Ino, what is even more pathetic is he thinks he can change the price by posting on a message board.
" I believe SNY is now going after BMRN."
The fact that you and Lurker own BMRN wouldn't have anything to do with your opinion on this would it?
I think the article made some valid points about valuation, (although anything is possible) I would imagine SNY are too cheap to go after a company as pricey as BMRN
He's unifying his base, even attacking Mexican American Republicans. White supremacists, skin heads, Klan members, you name the hate group, they think Trump is a God.
It's a strong statement when two former Republican presidents and many Republican governors, senate and congressmen would rather abstain from voting then support Trump.
Its a tough year when no viable candidates are running for office, better bring in the third runner option.